| Entry |
|
| Name |
HBV HBe to TLR2/4-NFKB signaling pathway
|
| Definition |
C -| TIRAP |
| Expanded |
K23129 -| 114609 |
| Class |
|
| Type |
Pathogen
|
| Pathway |
|
| Disease |
| H00048 | Hepatocellular carcinoma |
|
| Gene |
| 114609 | TIRAP; TIR domain containing adaptor protein |
|
| Perturbant |
| K23129 (C) | C; HBV capsid protein |
|
| Reference |
|
| Authors |
Revill P, Yuan Z |
| Title |
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection. |
| Journal |
|
| Reference |
|
| Authors |
Walsh R, Locarnini S |
| Title |
Hepatitis B precore protein: pathogenic potential and therapeutic promise. |
| Journal |
|
| Reference |
|
| Authors |
Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A |
| Title |
The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. |
| Journal |
|
| LinkDB |
|